Two-dimensional Echocardiographic Assessment of Myocardial Strain: Important Echocardiographic Parameter Readily Useful in Clinical Field

Park, Jae‐Hyeong

doi:10.4070/kcj.2019.0200

Cited by 28 publications

(26 citation statements)

References 127 publications

(154 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…GLS is a more sensitive predictor of left ventricular dysfunction than LVEF and provides additional prognostic value to LVEF. It can also predict subclinical myocardial dysfunction before overt cardiovascular diseases, even in asymptomatic patients [ 24 ]. The diagnostic and prognostic role of STE has been demonstrated in different clinical settings such as LV hypertrophy, cardio-oncology, valvular diseases, and cardiomyopathies [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

Hidden danger of COVID-19 outbreak: evaluation of subclinical myocardial dysfunction in patients with mild symptoms

Gül

İnci

Aktaş

et al. 2021

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

The COVID-19 infection, which is caused by the novel coronavirus SARS-CoV-2, has rapidly emerged as a global public health issue. Cardiac complications secondary to this infection are common and associated with mortality. This study aimed to evaluate whether subclinical myocardial dysfunction exists in non-hospitalized mildly symptomatic COVID-19 patients using left ventricular global longitudinal strain (LVGLS). In this cross-sectional, single-center study, data were collected from non-hospitalized mildly symptomatic COVID-19 patients between January 01 and February 01, 2021. Fifty (26 male, 24 female) COVID-19 patients and 50 age- and sex-matched healthy volunteers were included in the study. Apical four-, three-, and two-chamber images were analyzed longitudinally by conventional methods and speckle tracking echocardiography (STE) for left ventricle functions. The mean age of the COVID-19 patients was 39.5 ± 8.96, and 52% of them were male. The most prevalent presenting symptoms were fever [in 34 (68%)], asthenia [in 30 (60%)], loss of appetite [in 21 (42%)], myalgia [in 20 (40%)], and cough [in 13 (26%)]. Plasma levels of C-reactive protein (CRP) were significantly higher in the COVID-19 patients than in the controls (10.84 ± 12.44 vs. 4.50 ± 2.81, p < 0.001). There was no significant difference between the groups in terms of standard echocardiography and Doppler parameters (p > 0.05). Left ventricular longitudinal strain and strain velocity parameters were significantly decreased in COVID-19 patients compared to healthy individuals. LV-GLS values (− 21.72 ± 3.85% vs. − 23.11 ± 4.16%; p = 0.003) were significantly lower in COVID-19 patients compared with the healthy controls. Mildly symptomatic COVID-19 patients also have subclinical myocardial dysfunction similar to hospitalized patients. STE has the potential for detecting subclinical LV systolic dysfunction, and can provide useful information regarding cardiac status in mildly symptomatic COVID-19 population.

show abstract

Section: Discussionmentioning

confidence: 99%

Hidden danger of COVID-19 outbreak: evaluation of subclinical myocardial dysfunction in patients with mild symptoms

Gül

İnci

Aktaş

et al. 2021

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

show abstract

“…GLS is a more sensitive predictor of left ventricular dysfunction than LVEF and provides additional prognostic value to LVEF. It can also predict subclinical myocardial dysfunction before overt cardiovascular diseases, even in asymptomatic patients [24]. The diagnostic and prognostic role of the STE has been demonstrated in different clinical settings such as LV hypertrophy, cardio-oncology, valvular diseases, and cardiomyopathies [25].…”

Section: Discussionmentioning

confidence: 99%

Hidden Danger of COVID-19 Outbreak: Evaluation of Subclinical Myocardial Dysfunction in Patients with Mild Symptoms

Gül

İnci

Aktaş

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: The COVID 19 infection, which is caused by the novel coronavirus SARS-CoV-2, has rapidly emerged as a global public health issue. Cardiac complications secondary to this infection are common and associated with mortality. This study aimed to evaluate whether subclinical myocardial dysfunction using left ventricular global longitudinal strain (LVGLS) in non-hospitalized mildly symptomatic COVID-19 patients.Methods: In this cross-sectional, single-center study, data were collected from non-hospitalized mildly symptomatic COVID-19 patients between January 01 and February 01, 2021. Fifty (26 male, 24 female) COVID-19 patients and 50 age- and sex-matched healthy volunteers have included in the study. Apical four-, three-, and two-chamber images were analyzed longitudinally by conventional methods and speckle tracking echocardiography (STE) for left ventricle functions.Results: The mean age of the COVID-19 patients was 39.55±8.96, 52% of them were male. The most prevalent presenting symptoms were fever (in 34 (68%)), asthenia (in 30 (60%)), loss of appetite (in 21 (42%)), myalgia (in 20 (40%)), and cough (in 13 (26%)). Plasma levels of C-reactive protein (CRP) were significantly higher in the COVID-19 patients than in the controls (10.84±12.44 vs. 4.50±2.81, p < 0.001). There was no significant difference between the groups in terms of standard echocardiography and Doppler parameters (p>0.05). Left ventricular longitudinal strain and strain velocity parameters were significantly decreased in COVID-19 patients compared to healthy individuals. LV-GLS values (-21,72 ± 3,85% vs. -23,11 ± 4,16%; P =0,003) were significantly lower in COVID-19 patients when compared with the healthy controls.Conclusion: Mildly symptomatic COVID-19 patients also have subclinical myocardial dysfunction similar to hospitalized patients. STE has the potential for detecting subclinical LV systolic dysfunction and can provide useful information on the risk stratification in the mildly symptomatic COVID-19 population.

show abstract

“…Миокардиальная деформация может дать более точную информацию о функции миокарда, а также может быть использована для выявления ранних стадий ССЗ, мониторинга изменений миокарда при различных методах лечения, чтобы дифференцировать кардиомиопатии и прогнозировать прогноз некоторых ССЗ [33]. В настоящее время признается, что раннее выявление ССЗ может улучшить качество жизни пациентов и снизить как заболеваемость, так и смертность [34].…”

Section: клиническое применение Speckle Tracking-эхокг для диагностики дисфункции лжunclassified

Features of speckle tracking echocardiography for diagnosis of myocardial dysfunction

et al. 2021

View full text Add to dashboard Cite

Despite the undoubted success in the diagnosis of heart failure using echocardiography, the issue of detecting diastolic dysfunction of the left ventricle of the heart in the early stages remains insufficiently studied. The article describes a non-invasive ultrasound method for evaluating myocardial function, which allows early detection of left ventricle diastolic dysfunction due to myocardial fibrosis.

show abstract

Two-dimensional Echocardiographic Assessment of Myocardial Strain: Important Echocardiographic Parameter Readily Useful in Clinical Field

Cited by 28 publications

References 127 publications

Hidden danger of COVID-19 outbreak: evaluation of subclinical myocardial dysfunction in patients with mild symptoms

Hidden danger of COVID-19 outbreak: evaluation of subclinical myocardial dysfunction in patients with mild symptoms

Hidden Danger of COVID-19 Outbreak: Evaluation of Subclinical Myocardial Dysfunction in Patients with Mild Symptoms

Features of speckle tracking echocardiography for diagnosis of myocardial dysfunction

Contact Info

Product

Resources

About